Fermenta Biotech Ltd manufactures Active Pharmaceutical Ingredient, Aqua CHL, Biotechnology and Nutraceutical productsBusiness Overview: a) FBL is engaged in development and manufacturing of pharmaceuticals, biotechnology and environmental solutions used across various industries. It is a global player in manufacturing of Vitamin D3 in all its formats and has a non-China...
Fermenta Biotech has released its unaudited financial results for the quarter ended June 30, 2025. The company has confirmed the publication of these results in leading newspapers, ensuring public dissemination of its latest financial performance. This update provides stakeholders with access to key data for reviewing the company's recent operational...
Fermenta Biotech has reported strong Q1FY26 consolidated financial results. Net profit soared to INR 21.6 Cr, a significant turnaround from a INR 5.9 Cr loss last year. Revenue climbed 79% year-over-year to INR 145 Cr, while EBITDA jumped 922% to INR 37 Cr. This growth was driven by robust volume...
Fermenta Biotech's 73rd AGM presentation highlights a robust FY25 financial turnaround. Consolidated revenue surged 39% to ₹481 Cr, marking a significant recovery from prior year losses, with EBITDA at ₹122 Cr and net profit at ₹76 Cr. The company's strategic realignment, focusing on execution and innovation, delivered these results. Key...
Fermenta Biotech has secured a Certificate of Suitability (CEP) from the EDQM for its VITADEETM 100 SD product, a key spray-dried Vitamin D3 variant manufactured at its Kullu facility. This significant approval validates the product's adherence to global quality standards. Fermenta is now one of only two companies worldwide with...
Fermenta Biotech has informed that it has published a notice for its equity shareholders in prominent newspapers, Business Standard and Sakal. This signifies the company's commitment to disseminating important information broadly, ensuring transparency and timely updates for all shareholders. Investors should look out for the content of this shareholder notice...
